Eleven men with major depression and human immunodeficiency virus (HIV)
infection underwent an open trial of imipramine. Eight of nine (89%) who
completed 12 weeks responded. The mean decline in T4 cells from baseline
was 100 at week 12 and 16 at week 26. No major exacerbations of HIV
infection occurred.
Abstract Teaser